Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Y-mAbs Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for YMAB.
You can purchase shares of Y-mAbs Therapeutics (NASDAQ:YMAB) through any online brokerage.
Other companies in Y-mAbs Therapeutics’s space includes: Voyager Therapeutics (NASDAQ:VYGR), Monopar Therapeutics (NASDAQ:MNPR), Tevogen Bio Holdings (NASDAQ:TVGN), Anika Therapeutics (NASDAQ:ANIK) and Eledon Pharmaceuticals (NASDAQ:ELDN).
Y-mAbs Therapeutics has a consensus price target of $18.07.
The stock price for Y-mAbs Therapeutics (NASDAQ: YMAB) is $4.8 last updated April 2, 2025 at 4:24 PM EDT.
There are no upcoming dividends for Y-mAbs Therapeutics.
Y-mAbs Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
There is no upcoming split for Y-mAbs Therapeutics.
Y-mAbs Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.